2010
DOI: 10.1016/s0960-8966(10)70058-4
|View full text |Cite
|
Sign up to set email alerts
|

P43 Acetazolamide response in patients affected by hypokalemic periodic paralysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
0
0
Order By: Relevance
“…1,9 It should be noted that about 50% of genotyped patients respond to acetazolamide, most with the Ca 2þ channel mutation, exacerbation of the condition being reported with its use in patients with the Na þ channel mutation. 1,10 An attack can be staved off with commencement of gentle exercise at its onset, but the mainstay of treatment acutely is K þ replacement, either orally with 0.2-0.4 mmol/kg every 30 minutes (maximum 250 mmol per day) or intravenously with 40 mmol/L in 5% mannitol at 20 mmol/hour (maximum 250 mmol per day). 1 HypoKPP and pregnancy.…”
Section: Features Of Hypokppmentioning
confidence: 99%
“…1,9 It should be noted that about 50% of genotyped patients respond to acetazolamide, most with the Ca 2þ channel mutation, exacerbation of the condition being reported with its use in patients with the Na þ channel mutation. 1,10 An attack can be staved off with commencement of gentle exercise at its onset, but the mainstay of treatment acutely is K þ replacement, either orally with 0.2-0.4 mmol/kg every 30 minutes (maximum 250 mmol per day) or intravenously with 40 mmol/L in 5% mannitol at 20 mmol/hour (maximum 250 mmol per day). 1 HypoKPP and pregnancy.…”
Section: Features Of Hypokppmentioning
confidence: 99%